Agios Pharmaceuticals Corporation
Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
The intellectual property of Agios Pharmaceuticals includes 170 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Agios Pharmaceuticals has registered 28 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
The intellectual property of Agios Pharmaceuticals includes 170 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Agios Pharmaceuticals has registered 28 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Technology:
Drug Discovery
Industry:
Pharma
Headquarters:
The United States
Founded Date:
1/1/2008
Employees Number:
101-250
Funding Status:
IPO
Total Funding:
119823937
Last Funding Type:
Series C
Register and Claim Ownership